Document Type : Original Article

Authors

1 Department of Chemistry, Khajeh Nasir Toosi University of Technology, Tehran, Iran

2 Research Center Karaj Moallem, Karaj, Iran

Abstract

Invasive ductal carcinoma (IDC) breast cancer is one of the most common types of breast cancer among women, with a relatively high mortality rate. Introducing new diagnostic methods to the medical field can lead to a reduction in mortality. One of these methods is statistical monitoring and social screening of people with high risk of IDC cancer. Accordingly, many variables involved in the IDC occurrence should be identified and valued and finally classified. These variables include genetic factors involved in the IDC occurrence, environmental and unknown parameters. Addressing each of the factors requires extensive research. However, in this study, it has been tried to use three effective factors in the IDC occurrence, which include age, HR/HER2 status, and race, to provide a statistical model of the IDC occurrence. This information is reported based on the research of the American Cancer Society for 5 different races, aged 20 to over 79 and with different HR/HER2 status. In this study, a statistical analysis has been done based on the age, HR/HER2 status, and race. To provide a visual presentation of statistical analysis, Koch curve has been used with Python software, which is the best curve to show the progress of IDC disease. The results showed that people in the age group of 60 to 69, with HR+/HER2- status and white race are the people with higher probability of IDC. People in the age group of 20 to 39, with HR-/HER2+ status and with black race are less likely to develop IDC. In the same way, people with characteristics between these two states can be ranked.

Graphical Abstract

Statistical analysis of IDC breast cancer and its representation with Koch fractal curves to prognosis

Keywords

Main Subjects

OPEN ACCESS

©2024 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

PUBLISHER NOTE

Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.

CURRENT PUBLISHER

Sami Publishing Company

[1]. He Z., Chen Z., Tan M., Elingarami S., Liu Y., Li T., Deng Y., He N., Li S., Fu J. A review on methods for diagnosis of breast cancer cells and tissues, Cell proliferation, 2020, 53:e12822 [Crossref], [Google Scholar], [Publisher]
[2]. Kanavati F., Tsuneki M. Breast invasive ductal carcinoma classification on whole slide images with weakly-supervised and transfer learning, Cancers, 2021, 13:5368 [Crossref], [Google Scholar], [Publisher]
[3]. Philadelpho Arantes Pereira F., Martins G., Gregorio Calas M.J., Fonseca Torres de Oliveira M.V., Gasparetto E.L., Barbosa da Fonseca L.M. Magnetic resonance imaging-radioguided occult lesion localization (ROLL) in breast cancer using Tc-99m macro-aggregated albumin and distilled water control, BMC Medical Imaging, 2013, 13:1 [Crossref], [Google Scholar], [Publisher]
[4]. Zheng J., Yu J., Zhou T. Clinical characteristics of breast ductal carcinoma in situ with microinvasion: A narrative review, Journal of International Medical Research, 2020, 48:0300060520969304 [Crossref], [Google Scholar], [Publisher]
[5]. Chan A., Tuszynski J.A. Automatic prediction of tumour malignancy in breast cancer with fractal dimension, Royal Society open science, 2016, 3:160558 [Crossref], [Google Scholar], [Publisher]
[6]. Farina I., Goodall R., Hernández-Nava E., di Filippo A., Colangelo F., Fraternali F. Design, microstructure and mechanical characterization of Ti6Al4V reinforcing elements for cement composites with fractal architecture, Materials & Design, 2019, 172:107758 [Crossref], [Google Scholar], [Publisher]
[7]. Giaquinto A.N., Sung H., Miller K.D., Kramer J.L., Newman L.A., Minihan A., Jemal A., Siegel R.L. Breast cancer statistics, 2022, CA: a cancer journal for clinicians, 2022, 72:524 [Crossref], [Google Scholar], [Publisher]
[8]. Delides A., Panayiotides I., Alegakis A., Kyroudi A., Banis C., Pavlaki A., Helidonis E., Kittas C. Fractal dimension as a prognostic factor for laryngeal carcinoma, Anticancer Research, 2005, 25:2141 [Google Scholar], [Publisher]
[9]. Chan A.,Tuszynski J.A. Automatic prediction of tumour malignancy in breast cancer with fractal dimension, Royal Society open science, 2016, 3:160558 [Crossref], [Google Scholar], [Publisher]
[10]. Adyani Kalvanagh P., Adyani Kalvanagh Y. Investigating the Expression Levels of Glutathione Peroxidase and Glutathione Reductase Genes in Mastectomies Women, International Journal of Advanced Biological and Biomedical Research, 2023, 11:115 [Crossref], [Google Scholar], [Publisher]
[11]. Adyani Kalvanagh P., Adyani Kalvanagh Y. Evaluation of the effects of siRNA on Snail1 and miR-143 gene expression levels in metastatic female breast cancer cells during mastectomy, International Journal of Advanced Biological and Biomedical Research, 2023, 11:56 [Crossref], [Publisher]
[12]. Adyani Kalvanagh P., Adyani Kalvanagh Y. An Overview of Mastectomy and Its Types in the Treatment of Breast Cancer, International Journal of Advanced Biological and Biomedical Research, 2023, 11:25 [Crossref], [Publisher]
[13]. Adyani Kalvanagh P., Adyani Kalvanagh Y. Investigating the Relationship Between A/T 251 Polymorphism of IL-8 Gene and Cancer Recurrence After Lumpectomy, Eurasian Journal of Science and Technology, 2023, 3:173 [Crossref], [Publisher]
[14]. Adyani Kalvanagh P., Adyani Kalvanagh Y. Comparison of Exons 2 and 3 of DIRAS3 Gene in Mastectomies and Lumpectomies Women, Eurasian Journal of Science and Technology, 2023, 3:150 [Crossref], [Publisher]
[15]. Nasseri A.R., Mahdavi F. Evaluation of Breast Cancer Markers in Women Candidates for Mastectomy, Eurasian Journal of Science and Technology, 2023, 3:1 [Crossref], [Publisher]
[16]. Sharma S. A Short Review of Past, Present, and Future of Metallocene and Its Derivatives as an Effective Therapeutic Agent, Journal of Applied Organometallic Chemistry, 2023, 3:142 [Crossref], [Google Scholar], [Publisher]
[17]. Asirvatham S., Thakor E., Jain H., Morpholine T. Privileged Scaffold Possessing Diverse Bioactivity Profile, Journal of Chemical Reviews, 2021, 3:247 [Crossref], [Google Scholar], [Publisher]
[18]. Mezoughi A.B., Abdussalam-Mohammed W., Ettarhouni Z.O. Recent Biological Applications and Chemical Synthesis of Thiohydantoins, Journal of Chemical Reviews, 3:196 [Crossref], [Google Scholar], [Publisher]
[19]. Lakshmidevi V.R., Reeja D., Rajan A.R., Vinod B. Advanced Spectrum of Imidazole Derivatives in Therapeutics: A Review, Journal of Chemical Reviews, 2023, 5:241 [Crossref], [Publisher]